PHARMACOGENOMICS 润色咨询

PHARMACOGENOMICS

出版年份:暂无数据 年文章数:1847 投稿命中率: 开通期刊会员,数据随心看

出版周期:Semimonthly 自引率:10.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=24ae6810, cover=https://img.medsci.cn/images/journal/cover/2021/Aie_202109271316192630.jpg, fullname=PHARMACOGENOMICS, abbr=PHARMACOGENOMICS, pyear=暂无数据, frequence=Semimonthly, articleNumbers=1847, citedSelf2015=10.3, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3.25月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1462-2416, greenSci=https://www.greensci.net/search?kw=1462-2416, scijournal=https://www.scijournal.org/impact-factor-of-PHARMACOGENOMICS.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.953, medsciHotlight=2.841, medsciHotlight5year=3.2605, citescore=3.6, hIndex=91, impactFactor=2.1, orgnization=Future Medicine Ltd., orgnizationUrl=http://futuremedicine.com/, country=United Kingdom, countryCn=英国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 3区, smallclassCas=医学 4 区, website=http://www.futuremedicine.com/loi/pgs, websiteHits=6732, guideForAuthor=null, guideForAuthorHits=4, submitWebsite=https://www.futuremedicine.com/page/onlinesubmissions, submitWebsiteHits=1681, content=Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. Pharmacogenomics focuses on those aspects that have the most direct relevance to the pharmaceutical industry and wider clinical community, including: The emergence of new pharmacogenomic initiatives and their impact on R&D and regulatory strategies; Emerging technologies for accessing and exploiting genomic information; Reviews of genotyping and clinical data in particular therapeutic areas; Development of novel diagnostic products and strategies. Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field., totalCites=3879, brief=PHARMACOGENOMICS杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的中等级别杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=24ae6810'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=1475, tagName=基因组学, createdHits=4), ImpactFactorTagDto(id=57675, tagName=药物基因组学, createdHits=2)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=2.18), GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.17), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.23), GetImpactFactorCiteScoreListResponse(year=2019, citescore=3.7), GetImpactFactorCiteScoreListResponse(year=2020, citescore=3.6)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=3.384), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=3.023), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.387), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=2.132), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.953)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=133/300), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Genetics , rank=165/318), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=98/165)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q1)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1462-2416[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=PHARMACOGENOMICS[ta], article_number=79, article_number_cn=14, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
PHARMACOGENOMICS/PHARMACOGENOMICS
ISSN
1462-2416
影响指数话题
预警等级
MedSci期刊指数
1.953 (MedSci实时期刊指数) | 3.2605 (5年期刊指数)
CiteScore值
3.6
h-index
91
h5-median
暂无数据
出版社/管理机构
杂志由 Future Medicine Ltd. 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Semimonthly
出版年份
暂无数据
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews
JCR分区
PHARMACOLOGY & PHARMACY Q1
中科院分区
大类:医学 3区
小类:医学 4 区